Market Overview

Benzinga's Top Initiations

Share:
Benzinga's Top Initiations
Related PFE
PreMarket Prep Recap, March 21: We Haven't Seen A 2% Correction Since The Election
Anatomy Of A Decision, Part 1: The C-Suite
European advisory committee backs approval of Pfizer's meningococcal vaccine (Seeking Alpha)
Related LNKD
Money Is Energy: A Profile Of Family Office And Silk Legend Thomas Gütermann
The Grandest Social Media Lawsuits And Their Aftermath
With Snap Furor Twitter Has Been Cast Aside, But Is It Deserved? (Seeking Alpha)

Analysts at Citigroup initiated coverage on shares of Pfizer (NYSE: PFE) with a “buy” rating. Pfizer's shares closed at $24.85 yesterday. Pfizer's trailing-twelve-month operating margin is 31.27%.

Wedbush initiated coverage on shares of LinkedIn (NYSE: LNKD) with a “neutral” rating. LinkedIn's stock closed at $107.11 yesterday. LinkedIn's trailing-twelve-month ROE is 2.76%.

Wells Fargo initiated coverage on shares of Hess (NYSE: HES) with a “market perform” rating. Hess' shares closed at $50.50 yesterday. Hess had $528.00 million in total cash for the recent quarter.

Analysts at Mizuho initiated coverage on shares of Salix Pharmaceuticals (NASDAQ: SLXP) with a “buy” rating. Salix's shares closed at $41.26 yesterday. Salix's PEG ratio is 0.62.

Latest Ratings for PFE

DateFirmActionFromTo
Dec 2016GuggenheimInitiates Coverage OnNeutral
Nov 2016BarclaysUpgradesEqual-WeightOverweight
Nov 2016BMO CapitalDowngradesOutperformMarket Perform

View More Analyst Ratings for PFE
View the Latest Analyst Ratings

Posted-In: Top InitiationsInitiation Analyst Ratings

 

Related Articles (HES + LNKD)

View Comments and Join the Discussion!